Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson J. L., Rodier H. E., Green L. S. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am J Cardiol. 1983 Apr;51(7):1196–1202. doi: 10.1016/0002-9149(83)90368-5. [DOI] [PubMed] [Google Scholar]
- Hall J. A., Kaumann A. J., Brown M. J. Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium. Circ Res. 1990 Jun;66(6):1610–1623. doi: 10.1161/01.res.66.6.1610. [DOI] [PubMed] [Google Scholar]
- Hall J. A., Petch M. C., Brown M. J. In vivo demonstration of cardiac beta 2-adrenoreceptor sensitization by beta 1-antagonist treatment. Circ Res. 1991 Oct;69(4):959–964. doi: 10.1161/01.res.69.4.959. [DOI] [PubMed] [Google Scholar]
- Hall J. A., Petch M. C., Brown M. J. Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart. Circ Res. 1989 Sep;65(3):546–553. doi: 10.1161/01.res.65.3.546. [DOI] [PubMed] [Google Scholar]
- Kaumann A. J., Hall J. A., Murray K. J., Wells F. C., Brown M. J. A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J. 1989 Jun;10 (Suppl B):29–37. doi: 10.1093/eurheartj/10.suppl_b.29. [DOI] [PubMed] [Google Scholar]
- Kaumann A. J., Lemoine H. Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn Schmiedebergs Arch Pharmacol. 1987 Apr;335(4):403–411. doi: 10.1007/BF00165555. [DOI] [PubMed] [Google Scholar]
- McCance A. J., Forfar J. C. Myocardial ischaemia and ventricular arrhythmias precipitated by physiological concentrations of adrenaline in patients with coronary heart disease. Br Heart J. 1991 Oct;66(4):316–319. doi: 10.1136/hrt.66.4.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norris R. M., Barnaby P. F., Brown M. A., Geary G. G., Clarke E. D., Logan R. L., Sharpe D. N. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet. 1984 Oct 20;2(8408):883–886. doi: 10.1016/s0140-6736(84)90651-2. [DOI] [PubMed] [Google Scholar]
- Rydén L., Ariniego R., Arnman K., Herlitz J., Hjalmarson A., Holmberg S., Reyes C., Smedgård P., Svedberg K., Vedin A. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med. 1983 Mar 17;308(11):614–618. doi: 10.1056/NEJM198303173081102. [DOI] [PubMed] [Google Scholar]
- Toivonen L., Kadish A., Morady F. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia. Circulation. 1991 Jul;84(1):101–108. doi: 10.1161/01.cir.84.1.101. [DOI] [PubMed] [Google Scholar]
- Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]
